A Practical Approach to Neural-Progenitor Cell Manufacturing

Slides:

Advertisements

Similar presentations

Stem cells: disease models and therapeutics

Advertisements

Anatomy Class Projects are on the Cutting Edge Anatomy class is a place where we really do have a skeleton in the closet.

Spinal Cord Injury & Damage Reverend Kyle H. Hatashita D.D. Block 3 Honors Mrs. Jensen.

The Chinese University of Hong Kong Prince of Wales Hospital Role of Convalescence Serum In SARS Patients.

{ Targeting and killing of malignant gliomas by specific stem cells expressing a suicide gene.

Worldwide, an estimated 2.5 million people live with spinal cord injury (SCI), with more than 130,000 new injuries reported each year. SCI has a significant.

The Ethics of Stem Cell Research Presented by Corey Gomes Bme 181 April 15, 2013.

Stem Cells. Differentiation The process by which cells specialize into different types of cells Some cells become heart cells, brain cells, liver cells,

STEM CELL RESEARCH. Pros or Cons KX7lfmv-KQCFVB95QodVDwNigstem cell research

Human Embryonic Stem Cells: Considerations for Therapeutic Development Jane Lebkowski Ph.D. Geron Corporation Cell, Tissue and Gene Therapy Advisory Committee.

Central Nervous System and Epidermis. Neurulation What are the major derivatives of the ectoderm? What are the major derivatives of the ectoderm?

Spinal Cord Injury The average age of our patients with traumatic spinal cord injuries in 2013 was 46 years. The average age of our.

Using Stem Cells to Treat Ailments of the Nervous System Crista Chavez, Jacqueline Doody, Nina Roxo, Aleksandra Sabov & Zachary Taylor Faculty Mentor:

American Board of Dermatology Template for Self-Assessment Exercises.

Comments of International Society for Cellular Therapy (ISCT) to FDA Cellular, Tissue, & Gene Therapies Advisory Committee Elizabeth Read, MD March 30,

Spinal cord injury patients often succumb to bed sores Christopher Reeve dedicated his final years to promoting cutting-edge research in paralysis, including.

Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.

We have been hearing about this stem cell lately but does everyone know about what this really is? According to medical researchers, stem cell treatments.

Production of Nylon 66 Using Bio-Based Feedstock

34.4 Reproductive System Day 3.

Stem Cells: Scientific Potential and Alternatives

New Advance in Back Pain Treatment: Stem Cell Therapy

Alex Cart Frank Cummings

Continuous Production of Nylon-6,6

Improved Neural Regeneration with Olfactory Ensheathing Cell Inoculated PLGA Scaffolds in Spinal Cord Injury Adult Rats Neurosignals 2017;25:1–14 - DOI: /

Spinal Cord Injury Lawsuits

Joint Ventures and the Option to Expand and Acquire

Rebecca J. Carlson and Ariel M. Rose

Factors Complicating Treatment Sessions in Spinal Cord Injury Rehabilitation: Nature, Frequency, and Consequences Marcel P. Dijkers, PhD, FACRM, Jeanne.

Figure 1 CONSORT flow diagram of study participation from enrollment to analysis. RIMT=resistive inspiratory muscle training. Asterisk indicates data missing.

From: NEURAL STEM CELLS FOR BRAIN AND SPINAL CORD REPAIR  Tanya Zigova, Evan Snyder and Paul Sanberg, editors.  Totowa (NJ)  Humana Press  Price.

From: Polarized Secretion of PEDF from Human Embryonic Stem Cell–Derived RPE Promotes Retinal Progenitor Cell Survival Invest. Ophthalmol. Vis. Sci ;52(3):

V. Bordoni, M. Bibas, I. Abbate, D. Viola, G. Rozera, C. Agrati, A

Genetic Engineering, Stem Cells, and Cloning

Manufacturing Nylon 66 from the Ground Up

Research Live Presentation Template

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Maintaining Shoulder Health After Spinal Cord Injury: A Guide to Understanding Treatments for Shoulder Pain Meegan G. Van Straaten, PT, MSPH, Beth A.

Supplemental figure 1 A B C

Manabu Ohyama, Hideyuki Okano Journal of Investigative Dermatology

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Exploring Personalized Prophylaxis in Hemophilia A

Neural Stem Cell Therapy and Gastrointestinal Biology

Nat. Rev. Neurol. doi: /nrneurol

Traumatic Brain Injury in Patients With Traumatic Spinal Cord Injury: Clinical and Economic Consequences Cheryl L. Bradbury, PsyD, CPsych, Walter P.

Case Study Retrospective review of patient’s medical record with intent to document a specific situation or the experience of an individual without intent.

Letermovir(Prevymis™) Guidelines for Inpatient Use

Journal of the American College of Surgeons

Group 2: Rebecca, Katie and Georgina

Electrical Stimulation Therapy Increases Rate of Healing of Pressure Ulcers in Community-Dwelling People With Spinal Cord Injury Pamela E. Houghton,

# of Neural Stem Cells Produced/ Year

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Stem cell therapy for human cartilage defects: a systematic review

Lyandysha V. Zholudeva, Liang Qiang, Vitaliy Marchenko, Kimberly J

Longitudinal Patterns of Functional Recovery in Patients With Incomplete Spinal Cord Injury Receiving Activity-Based Rehabilitation Douglas J. Lorenz,

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

Batch Production of Monoclonal Antibodies

Equipment Cost Summary

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

A Prospective Study of Factors Influencing Return to Work After Traumatic Spinal Cord Injury in Taiwan Mau-Roung Lin, PhD, Hei-Fen Hwang, MS, Wen-Yu.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Production of Monoclonal Antibodies

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

NOTES 27 – Embryonic Stem Cells and Cloning

Balanced scales and equations

Modeling Brain Disease in a Dish: Really?

Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective.

Presentation transcript:

A Practical Approach to Neural-Progenitor Cell Manufacturing Manlet: Jon Silva, Nick Sweeney Cook, Aguedo De Los Santos Objectives: Design a practical process for the production of 100% pure Neural Progenitor cells for cellular therapy Produce a cost-effective treatment option for Americans suffering from spinal cord injuries (SCI’s) This is only a template. You may chose to use or not use this format. I highly recommend you use a format that works for your group. Process Flow Diagram and Material Balances Neural Cell Purification: Immunomagnetic Cell Sorting Economic Analysis Conclusions & Recommendations Stem cell therapies are budding technologies that are still in development, but appear to be profitable. Cutting-edge technologies like MACS may be used to produce high-purity cells for injury treatment. We highly recommend this process, or elements of this process, for the large-scale manufacture of neural progenitor cells for cellular therapies. Pricing Contributions: https://www.clevelandclinic.org/reproductiveresearchcenter/imglarge/innomale07_1.jpg $1,775/dose 100% Patient Acquisition cGMP Compliant R&D Focused